SEC Form 4 · accession 0001209191-17-059345
IMMUNE DESIGN CORP. · IMDZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis W Coleman
Director
Period of report
Nov 2, 2017
Accepted (ET)
Nov 6, 2017 · 9:15 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001437786
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 2, 2017 | P | 50,000 | $4.50 | A | 175,000 | I | By Trust |
| Common Stock | holding | — | — | — | 3,000 | I | By Wife's IRA |
Table II — derivative securities
No Table II lines on this filing.